Israel regulator warns of medical cannabis bubble, eyes Australia pact

JERUSALEM (Reuters) – Medical cannabis could become an investment bubble in Israel, the country’s market regulator warned, as cash floods into a rapidly-expanding industry where few companies yet make money.

A special unit has been formed by the Israel Securities Authority (ISA) to ensure investors are protected and not being misled, agency chair Anat Guetta told Reuters.

Guetta also said Israel may expand its dual-listing arrangements to include Australia as it tries to connect with more foreign markets and draw investors to recover trading volumes lost a decade ago.

One of the fastest growing segments on the Tel Aviv Stock Exchange (TASE) is medical cannabis and the sector got a boost in January when the government approved exports.

About 26 listed companies have a link to medical cannabis, up from 19 in December, with a combined market value of 3.4 billion shekels ($952 million). Most are at an early stage without revenues. Some shares are up hundreds of percent since the start of 2018.

“I don’t think that we can avoid a bubble,” Guetta said. “Bubbles are part of the nature of markets, of capital markets, but we can provide our investors the right tools to manage those risks properly.”

Though the onus ultimately lies with investors, she said the ISA had formed a special unit to monitor the sector while tightening disclosure requirements from companies in the field.

Benefiting from a favorable climate and expertise in medical and agricultural technologies, Israeli companies are among the world’s biggest producers of medical cannabis. Two former prime ministers and an ex-police chief are among high-profile individuals to join companies’ ranks.

Cannabis stocks may be high, but overall trade volumes are sluggish and have not recouped the flows lost when MSCI upgraded Israel to developed market status from emerging in 2010.

FILE PHOTO: An employee tends to medical cannabis plants at Pharmocann, an Israeli medical cannabis company in northern Israel January 24, 2019. REUTERS/Amir Cohen/File Photo

Tel Aviv share volumes averaged 1.1 billion shekels a day between January and April, down 19 percent from a 2018 average and half levels of a decade ago. In the same period, the TASE lost more than 150 listed companies.

To help lure new issuers, the bourse has forged dual-listing partnerships with markets in New York, Toronto, London, Singapore and Hong Kong.

“We are considering the ability to have such an arrangement with the Australian stock exchange and currently it’s under consideration,” Guetta said before flying to Sydney for a regulators conference. “Our visit will give us better knowledge about this issue.”

Twenty Israeli companies are listed in Australia and Australian groups own about 10 percent of the TASE, which was demutualized last year.

Separately, Guetta on Tuesday signed an agreement with her French counterpart to cooperate on innovation, investor protection and regulatory issues related to blockchain, crypto-assets and artificial intelligence.

The ISA has come under fire from some companies and investors for being heavy-handed, but Guetta, who took office last year, said the agency has eased the burden on companies.

More worrisome is that Israel’s own high-tech sector, widely regarded as second only to Silicon Valley, has bypassed the local bourse.

“The fact that money is very cheap and there is no regulation makes the private capital market very attractive for issuers,” Guetta said.

At the same time, institutional investors in Israel, who manage more than $500 billion of public savings, are unfamiliar with and so have largely stayed away from tech investments.

Slideshow (2 Images)

Now the ISA is forming a committee with industry leaders to try to bridge the gap, Guetta said, to coach them on pricing and research of tech companies.

To entice foreigners, Guetta said she was accelerating plans to allow companies to report in English in addition to Hebrew, and move to a more friendly reporting format.

Source

more recommended stories

  • Biohaven’s treatment for Lou Gehrig’s disease fails to win FDA nod

    FILE PHOTO: The logo for Biohaven.

  • WHO says investigators conclude Ebola victim did not enter Rwanda

    GENEVA (Reuters) – A Congolese woman.

  • Second opioid distributor charged over U.S. overdose crisis

    (Reuters) – An Ohio drug wholesale.

  • U.S. overdose deaths post annual drop for first time in two decades

    (Reuters) – U.S. overdose deaths dropped.

  • FDA finds ‘significant violations’ at India’s Strides plant

    (Reuters) – The U.S. Food and.

  • U.N. wants more urgency in AIDS fight as gains and funding fade

    LONDON (Reuters) – The global fight.

  • Oklahoma seeks to hold J&J responsible for opioid crisis as trial ends

    NORMAN, Okla. (Reuters) – Lawyers for.

  • Healthy living may help offset genetic risk of dementia: study

    LONDON (Reuters) – Living healthily with.

  • Democrats take aim as Trump abandons drug pricing plan

    WASHINGTON (Reuters) – Democrats see U.S..

  • U.S. appeals court blocks Trump administration birth control exemptions

    (Reuters) – A federal appeals court.

  • China vows to tackle dead pig scam amid swine fever epidemic

    FILE PHOTO: Piglets are seen by.

  • Alberta joins Ontario in pulling some CannTrust weed products

    TORONTO (Reuters) – Alberta is placing.

  • Trump administration pushes U.S. at-home kidney care, transplant availability

    NEW YORK/WASHINGTON (Reuters) – The Trump.

  • U.S. appeals court signals sympathy to bid to strike down Obamacare

    NEW ORLEANS (Reuters) – A federal.

  • U.S. judge strikes down Trump administration rule requiring drug prices in TV ads

    (Reuters) – A federal judge on.

  • Intra-Cellular drug fails one of two bipolar depression studies; shares fall

    (Reuters) – Intra-Cellular Therapies Inc said.

  • China reports new African swine fever outbreak in Guangxi region

    BEIJING (Reuters) – China’s southwestern region.

  • Weed ban means no Rocky Mountain high for Canada’s Calgary Stampede

    CALGARY, Alberta (Reuters) – Canada’s Calgary.

  • Weightlifting better at reducing heart fat than aerobic exercise

    Obese people who engaged in resistance.

  • Sydney’s city council reviews use of Bayer’s Roundup weed killer amid cancer fears

    SYDNEY (Reuters) – Sydney’s city council.

  • Bulgaria confirms two cases of African swine fever

    SOFIA (Reuters) – Bulgaria has confirmed.

  • FDA approves Karyopharm Therapeutics’ blood cancer drug

    (Reuters) – The U.S. Food and.

  • Facebook to tackle content with misleading health claims

    FILE PHOTO: The Facebook logo is.

  • FDA ties three deaths to Edwards Lifesciences’ recalled heart devices

    (Reuters) – The U.S. Food and.

  • India asks its states not to partner with Philip Morris-funded foundation

    NEW DELHI (Reuters) – India’s health.

  • U.S. federal court delays adoption of healthcare rule on abortion

    FILE PHOTO – A imaging table.

  • China tightens vaccine management after scandals

    FILE PHOTO – A nurse prepares.

  • U.S wages lost to unpaid family care to hit $147 billion by 2050

    As the U.S. population ages, the.

  • U.S. ‘gag rule’ linked to 40% jump in abortions in parts of Africa

    LONDON (Reuters) – A decades-old U.S..

  • Study shows major real-world impact of cervical cancer vaccines

    LONDON, June 26 (Reuters) – Vaccination.

  • Glyphosate use will eventually end, Merkel says

    German Chancellor Angela Merkel attends a.

  • Unproven stem cell therapies often peddled by doctors without training

    At U.S. clinics advertising unproven stem.